Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone.
Sporn
Michael B
MB
Department of Pharmacology, Dartmouth Medical School, Hanover, NH 03755, USA. michael.sporn@dartmouth.edu
Hong
Waun Ki
WK
D000236:Adenoma / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000473:pathology*; D000518:Eflornithine / Q000008:administration & dosage*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D013467:Sulindac / Q000008:administration & dosage*
D013467:Sulindac; D000518:Eflornithine